Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device
- PMID: 35734523
- PMCID: PMC9207944
- DOI: 10.1016/j.jaccas.2022.03.021
Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device
Abstract
An 80-year-old woman with mitral valve repair failure was admitted with hemolytic anemia secondary to the impact of a regurgitant jet on the annuloplasty ring. Transcatheter repair to treat both mitral regurgitation and hemolysis was favored because of surgical risk. Transcatheter edge-to-edge repair represents an alternative for treating hemolysis associated with mitral regurgitation. (Level of Difficulty: Advanced.).
Keywords: MR, mitral regurgitation; MVRe, [surgical] mitral valve repair; TEER, transcatheter-edge-to-edge repair; hemolysis; mitral valve repair; mitral regurgitation; transcatheter-edge-to-edge repair.
© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.
Conflict of interest statement
Drs Li, Millan, and Arzamendi have reported received proctoring and speaker fees from Abbott. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures






References
-
- Davidson L.J., Davidson C.J. Transcatheter treatment of valvular heart disease: a review. JAMA. 2021;325(24):2480–2494. - PubMed
-
- Sanchis L., Jorda P., Pereda D., et al. MitraClip implantation for hemolytic anemia treatment after surgical mitral valve repair. J Am Coll Cardiol Intv. 2020;13(9):e85–e86. - PubMed
Publication types
LinkOut - more resources
Full Text Sources